E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.
about
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@ast
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@en
type
label
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@ast
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@en
prefLabel
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@ast
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@en
P2093
P2860
P1476
E5501: phase II study of topot ...... -stage small-cell lung cancer.
@en
P2093
Eric H Rubin
Joan H Schiller
Joseph Aisner
Murugesan Gounder
Paul Gregory Rausch
Rita S Axelrod
Suresh S Ramalingam
Suzanne E Dahlberg
Taofeek K Owonikoko
Xin Victoria Wang
P2860
P2888
P304
P356
10.1007/S00280-013-2338-Z
P577
2013-11-28T00:00:00Z